Kelley Recognizes the Massachusetts Life Sciences Center for Its Aid to His Company
Beverly, MA — June 9, 2015 —InsomniSolv, a NSIV startup, is a biotech company that is currently designing a neurostimulator device to mitigate insomnia. After receiving a $84,000 grant from the Massachusetts Life Sciences Center, Peter Kelley, InsomniSolv’s CEO, has been able to begin planning clinical trials to be performed at Mass General Hospital. Kelley was recently interviewed about this achievement and how MLSC has contributed to his company’s progress.
Check out the article at www.wbur.org.
Leave a Comment